| P50 | author | Walter Fiers | Q2068397 |
| | Xavier Saelens | Q8043303 |
| P2093 | author name string | R Contreras | |
| | M Maras | |
| | S Neirynck | |
| | W Martinet | |
| | W M Jou | |
| | P Vanlandschoot | |
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis | Q29547610 |
| | Silver stain for proteins in polyacrylamide gels: A modified procedure with enhanced uniform sensitivity | Q29615342 |
| | Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness | Q29615389 |
| | Foreign gene expression in yeast: a review | Q34306722 |
| | Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion | Q36281287 |
| | Molecular and immunological characterization of soluble aggregated A/Victoria/3/75 (H3N2) influenza haemagglutinin expressed in insect cells | Q38363163 |
| | Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide | Q39752742 |
| | Activation of influenza A viruses by trypsin treatment | Q39965584 |
| | Molecular mechanisms of variation in influenza viruses | Q40102702 |
| | Variation of influenza A, B, and C viruses | Q40326626 |
| | Vaccine technologies: view to the future | Q40391972 |
| | Safety considerations for nucleic acid vaccines | Q40605753 |
| | The analysis of fluorophore-labeled glycans by high-resolution polyacrylamide gel electrophoresis | Q40750672 |
| | An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus | Q41021913 |
| | pH-dependent aggregation and secretion of soluble monomeric influenza hemagglutinin | Q41049938 |
| | Heterologous protection against influenza by injection of DNA encoding a viral protein | Q43828996 |
| | Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs | Q44077186 |
| | Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans | Q44817736 |
| | Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein | Q45771842 |
| | Recombinant secreted haemagglutinin protects mice against a lethal challenge of influenza virus | Q45777367 |
| | Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults | Q45785388 |
| | A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody | Q45788654 |
| | Evidence for host-cell selection of influenza virus antigenic variants | Q45804806 |
| | Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1 /80 (H7N7) influenza virus | Q45805094 |
| | Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin | Q45805493 |
| | Interference with a conformational change in the haemagglutinin molecule of influenza virus by antibodies as a possible neutralization mechanism | Q45827752 |
| | High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors | Q45840993 |
| | Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2. | Q45847561 |
| | Size distribution and general structural features of N-linked oligosaccharides from the methylotrophic yeast, Pichia pastoris. | Q45932552 |
| | Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. | Q48412786 |
| | Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. | Q48414076 |
| | Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase | Q49093623 |
| | Recombinant neuraminidase vaccine protects against lethal influenza | Q49167194 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 166-175 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | FEBS Journal | Q1388041 |
| P1476 | title | Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin | |
| P478 | volume | 260 | |